|

DM-BOOST Para Latinx: a Diabetes Mellitus Program Using Behavioral Economics to Optimize Outreach and Self-management Support With Technology for Latinx Patients

RECRUITINGN/ASponsored by Daniel Amante
Actively Recruiting
PhaseN/A
SponsorDaniel Amante
Started2024-12-01
Est. completion2026-01-01
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations2 sites

Summary

The specific aims of this project are to culturally adapt the DM-BOOST intervention for Latinx patients, usability test 'DM-BOOST para Latinx' to optimize cultural appropriateness and patient engagement and conduct a feasibility evaluation of DM-BOOST para Latinx. These aims will be accomplished via a community-based participatory research approach in collaboration with clinical, community and patient partners. This project will inform subsequent proposals to evaluate implementation of DM-BOOST in the UMass Memorial Health Care system.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Aims 1 and 2 Patient Inclusion Criteria:

* Age \> 18 years
* Diagnosis of type 2 diabetes
* Identifies as Hispanic/Latinx
* Spanish language preference

Aims 1 and 2 Patient Exclusion Criteria:

* Cognitive impairment
* Current prisoner
* Pregnant women

Aim 3 Patient Inclusion Criteria:

* Age \> 18 years
* Diagnosis of type 2 diabetes
* Identifies as Hispanic/Latinx
* Spanish language preference

Aim 3 Patient Exclusion Criteria:

* Cognitive impairment
* Current prisoner
* Pregnant women
* Completed DSMT in previous year

Conditions2

DiabetesDiabetes Mellitus, Type 2

Locations2 sites

UMass Memorial health
Worcester, Massachusetts, 01605
Daniel Amante, PhD, MPH5088568480daniel.amante@umassmed.edu
University of Massachusetts Medical School
Worcester, Massachusetts, 01655
Daniel Amante, PhD, MPH774-418-3645Daniel.Amante@umassmed.edu

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.